Komori
M&A and Subsidiary Changes6736SUNCORPORATIONElectrical Equipment and Precision Instruments

Notice Regarding the Receipt of Shares in Cellebrite, an Equity-Method Affiliate of the Company

As the share-price conditions for Cellebrite were met, the company decided to receive 3,489,202 Cellebrite shares at no cost as an adjustment to the consideration. The receipt of shares relating to the remaining conditions will be disclosed once confirmed.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
3489202
Shares
Wording
Definitive
How definitive the wording is.

This transaction

対価調整
Counterparty (target company)Cellebrite DI Ltd
Disclosing companySUNCORPORATION
Subject of this transactionNumber of shares acquired 3,489,202株、議決権の数はNot disclosed
Contract Date2021年4月8日
Consideration and expenses
Acquisition priceNo consideration
Type of Consideration株式(無償)
Impact on Business Performance

営業利益の予測に変更はございません。

Procedures and assumptions
Conditions Precedent to Executionクロージング日から5年以内の任意の30日間のうち20日間のCellebrite社のVWAPが12.5米ドル、15米ドル及び17.5米ドルを超えた場合等に、各条件を満たすごとに株式を発行する条件。
This transaction
ItemDetails
Transaction name対価調整
Counterparty nameCellebrite DI Ltd
Name of the Subject CompanyCellebrite DI Ltd
Acquisition priceNo consideration
Type of Consideration株式(無償)
Number of shares acquired3,489,202株、議決権の数はNot disclosed
Impact on Business Performance営業利益の予測に変更はございません。
Contract Date2021年4月8日
Conditions Precedent to Executionクロージング日から5年以内の任意の30日間のうち20日間のCellebrite社のVWAPが12.5米ドル、15米ドル及び17.5米ドルを超えた場合等に、各条件を満たすごとに株式を発行する条件。
Items this document does not state (23)
Business Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyExpenses other than the acquisition priceMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionExecution Date / Effective DateValuation methodologyIndependent valuation institutionSpecial CommitteeManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Cellebrite社の上場に伴う対価調整について、任意の30日間のうち20日間のVWAPが12.5米ドル、15.0米ドル、17.5米ドルの条件を満たしたため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Receipt of Shares in Cellebrite, an Equity-Method Affiliate of the Company | SUNCORPORATION (6736) timely disclosure | Komori